Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Volume Plasmapheresis for Refractory Hepatic Encephalopathy
NCT03115697Withdrawn
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in hepatic encephalopathy (HE) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Resolution in Hepatic Encephalopathy by 2 grades at Day 5. Planned start Apr 2018; status: withdrawn.
02
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03115697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03115697.